Daily Roundup

GTG.ASX SKK.ASX AWJ.ASX EIQ.ASX G6M.ASX

Genetic Technologies Abandons Acquisition Plans, Focuses on Relisting Opportunities

Genetic Technologies Ltd (ASX: GTG) has decided to abandon its previously announced plans to acquire Ellerfield Private Wealth. After a strategic review, the company's board determined that discontinuing the discussions is in the best interests of shareholders. Instead, Genetic Technologies will focus on alternative opportunities aligned with its proposed relisting strategy.

Stakk Secures Major US$5.5M Client Contract

Stakk Limited (ASX: SKK), a leading AI-native trust and decisioning infrastructure provider, has announced a significant new enterprise client contract in the United States. The 12-month agreement is worth A$7.85 million (US$5.5 million) and represents Stakk's largest individual client contract to date. This deployment is expected to drive the company's continued expansion across regulated U.S. sectors, building on its established presence in financial services and recent growth into telecommunications and healthcare.

Auric Mining Delivers Stellar Results from Munda Gold Mine

Auric Mining Ltd (ASX: AWJ) has reported excellent financial results from the Munda Gold Mine Starter Pit. All bullion was sold at an average of A$7,178 per ounce, resulting in net cash and debtors totaling A$43.5 million. Additionally, gold production exceeded budget by 46%, with the reconciled average head grade and recovery also surpassing expectations. Auric sees the Munda Main Pit as a major opportunity that reinforces the company's ambition to become a significant, sustainable gold producer.

Echo IQ Expands Mayo Clinic Partnership for Heart Failure AI

Echo IQ Limited (ASX: EIQ) has expanded its agreement with the Mayo Clinic to resell and distribute its FDA-cleared heart failure AI solution, EchoSolv HF, through the Mayo Clinic Platform. This revised agreement strengthens the commercial framework between the parties and supports the planned deployment of EchoSolv HF within the Mayo Clinic network. Following FDA clearance, Echo IQ is positioned to unlock a significant market opportunity, as heart failure represents a substantial and growing burden on the U.S. healthcare system.

Group 6 Metals Secures Multiyear Tungsten Offtake Extension

Group 6 Metals Ltd (ASX: G6M) has signed a multi-year offtake agreement extension with global commodities trading firm Traxys Europe S.A. Under the new agreement, Group 6 Metals will deliver a minimum of 10,000 MT of WO3 contained in scheelite concentrates over the next 6-8 years, with a minimum contract value of US$1.75 billion at current APT prices and exchange rates. This extension ensures continuity of access to global tungsten markets and provides significant benefits for both parties.